Dissecting the Decision: Investigators Discuss PARP Inhibition in the Management of Ovarian Cancer


Dissecting the Decision: Investigators Discuss PARP Inhibition in the Management of Ovarian Cancer
Proceedings from an independent satellite symposium during the Society of Gynecologic Oncology’s 2017 Annual Meeting on Women’s Cancer. Featuring perspectives from Drs Robert L Coleman, Jonathan A Ledermann, Ursula A Matulonis and Richard T Penson.
1.75 AMA PRA Category 1 Credits
To complete the Post-test and Educational Assessment and Credit Form, click here. A statement of CME credit will be issued for scores of 80% or better. Your statement of credit will be mailed to you within 3 weeks or may be printed online.